According to a newly published market research report by 24LifeSciences, the global heparin injectable preparation market was valued at USD 9.05 billion in 2024 and is projected to reach USD 14.29 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period.
Heparin, a naturally occurring glycosaminoglycan anticoagulant, remains a critical therapeutic...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek